OncoSenX is a pre-clinical biotechnology company headquartered in Seattle, Washington. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our system is comprised of two main components: An untargeted non-toxic lipid nanoparticle (LNP) for cellular delivery and a highly targeted DNA payload.

Contact OncoSenX
Visit Website